COEP - Coeptis Therapeutics Holdings, Inc.


9.3
0.050   0.538%

Share volume: 19,177
Last Updated: 04-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.07%

PREVIOUS CLOSE
CHG
CHG%

$9.25
0.05
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
21%
Profitability 0%
Dept financing 24%
Liquidity 24%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
-3.83%
1 Month
-14.68%
3 Months
22.85%
6 Months
5,133.54%
1 Year
2,291.36%
2 Year
604.55%
Key data
Stock price
$9.30
P/E Ratio 
0.00
DAY RANGE
$9.07 - $9.49
EPS 
-$7.43
52 WEEK RANGE
$0.13 - $13.70
52 WEEK CHANGE
$2,284.62
MARKET CAP 
11.308 M
YIELD 
N/A
SHARES OUTSTANDING 
39.719 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
1.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$24,474
AVERAGE 30 VOLUME 
$43,155
Company detail
CEO: David Mehalick
Region: US
Website: coeptispharma.com
Employees: 2
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Bull Horn Holdings Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded in 2018 and is based in Miami Beach, Florida.

Recent news
loading